Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AIVITA Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial

americanpharmaceuticalreviewNovember 20, 2018

Tag: patients , glioblastoma , AIVITA

PharmaSources Customer Service